β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells
- 29 April 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 122 (3), 365-374
- https://doi.org/10.1016/j.jconrel.2007.04.014
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachoneProceedings of the National Academy of Sciences, 2007
- Mixed micelles formed from graft and diblock copolymers for application in intracellular drug deliveryBiomaterials, 2007
- Calcium-dependent Modulation of Poly(ADP-ribose) Polymerase-1 Alters Cellular Metabolism and DNA RepairJournal of Biological Chemistry, 2006
- Modulating β‐lapachone release from polymer millirods through cyclodextrin complexationJournal of Pharmaceutical Sciences, 2006
- Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancerMolecular Carcinogenesis, 2005
- Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- μ-Calpain Activation in β-Lapachone-Mediated ApoptosisCancer Biology & Therapy, 2003
- Calcium Is a Key Signaling Molecule in β-Lapachone-mediated Cell DeathPublished by Elsevier BV ,2001
- Polymeric micelles – a new generation of colloidal drug carriersEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963